A detailed history of Motiv8 Investments LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Motiv8 Investments LLC holds 786 shares of LLY stock, worth $603,459. This represents 0.47% of its overall portfolio holdings.

Number of Shares
786
Previous 1,687 53.41%
Holding current value
$603,459
Previous $1.53 Billion 54.4%
% of portfolio
0.47%
Previous 1.14%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$772.14 - $960.02 $695,698 - $864,978
-901 Reduced 53.41%
786 $697 Million
Q2 2024

Aug 06, 2024

BUY
$724.87 - $909.04 $7,248 - $9,090
10 Added 0.6%
1,687 $1.53 Billion
Q1 2024

May 30, 2024

SELL
$592.2 - $792.28 $79,354 - $106,165
-134 Reduced 7.4%
1,677 $1.3 Billion
Q4 2023

May 30, 2024

BUY
$525.19 - $619.13 $951,119 - $1.12 Million
1,811 New
1,811 $1.06 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Motiv8 Investments LLC Portfolio

Follow Motiv8 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Motiv8 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Motiv8 Investments LLC with notifications on news.